IVBXF fundamentals
An in-depth look to Innovent Biologics Inc. operating, investing, and financing activities
IVBXF free cash flow for H2 23 is 49.85 M USD. For 2023, IVBXF free cash flow was -112.42 M USD and operating cash flow was 46.19 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM